Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714
Authors:
- Jinghai J. XuJXJinghai J. Xu
- Scott CampbellSCScott Campbell
- Vsevolod E. KostrubskyVKVsevolod E. Kostrubsky
- Arthur R. SmithASArthur R. Smith
- Huifen F. WangHWHuifen F. Wang
Open Access
- 17 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 108 (2) , 492-500
Abstract
CP-724,714, a potent and selective orally active HER2 tyrosine kinase inhibitor, was discontinued from clinical development due to unexpected hepatotoxicity in cancer patients. Based on the clinical manifestation of the toxicity, CP-724,714 likely exerted its hepatotoxicity via both hepatocellular injury and hepatobiliary cholestatic mechanisms. The direct cytotoxic effect, hepatobiliary disposition of CP-724,714, and its inhibition of active canalicular transport of bile constituents were evaluated in established human hepatocyte models and in vitro transporter systems. CP-724,714 exhibited direct cytotoxicity using human hepatocyte imaging assay technology with mitochondria identified as a candidate organelle for its off-target toxicity. Additionally, CP-724,714 was rapidly taken up into human hepatocytes, partially via an active transport process, with an uptake clearance approximately fourfold higher than efflux clearance. The major human hepatic uptake transporter, OATP1B1, and efflux transporters, multidrug resistance protein 1 (MDR1) and breast cancer resistance protein, were involved in hepatobiliary clearance of CP-724,714. Furthermore, CP-724,714 displayed a concentration-dependent inhibition of cholyl-lysyl fluorescein and taurocholate (TC) efflux into canaliculi in cryopreserved and fresh cultured human hepatocytes, respectively. Likewise, CP-724,714 inhibited TC transport in membrane vesicles expressing human bile salt export pump with an IC50 of 16μM. Finally, CP-724,714 inhibited the major efflux transporter in bile canaliculi, MDR1, with an IC50 of ∼28μM. These results suggest that inhibition of hepatic efflux transporters contributed to hepatic accumulation of drug and bile constituents leading to hepatocellular injury and hepatobiliary cholestasis. This study provides likely explanations for clinically observed adverse liver effects of CP-724,714.Keywords
This publication has 27 references indexed in Scilit:
- In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous SystemDrug Metabolism and Disposition, 2008
- Role of Transporters in the Disposition of the Selective Phosphodiesterase-4 Inhibitor (+)-2-[4-({[2-(Benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic Acid in Rat and HumanDrug Metabolism and Disposition, 2007
- Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase InhibitorCancer Research, 2007
- Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safetyCancer Chemotherapy and Pharmacology, 2007
- Uptake and Intracellular Binding of Lipophilic Amine Drugs by Isolated Rat Hepatocytes and Implications for Prediction of in Vivo Metabolic ClearanceDrug Metabolism and Disposition, 2006
- Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary TransportDrug Metabolism and Disposition, 2006
- Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemiaChemico-Biological Interactions, 2004
- Hepatic Uptake of Bilirubin and Its Conjugates by the Human Organic Anion Transporter SLC21A6Journal of Biological Chemistry, 2001
- Impaired Protein Maturation of the Conjugate Export Pump Multidrug Resistance Protein 2 As A Consequence of A Deletion Mutation in Dubin–Johnson SyndromeHepatology, 2000
- cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant RatsJournal of Biological Chemistry, 1996